Abstract
Background: No comprehensive meta-analysis has been performed concerning the efficacy and tolerability of histamine H3 receptor antagonists (H3R-ANTs) in Alzheimer's disease patients. Objective: We performed a systematic review and meta-analysis of double-blind randomized placebo-controlled trials (RCTs) of H3R-ANTs for Alzheimer's disease.
| Original language | English |
|---|---|
| Pages (from-to) | 667-671 |
| Number of pages | 5 |
| Journal | Journal of Alzheimer's Disease |
| Volume | 48 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 01-10-2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Geriatrics and Gerontology
- Psychiatry and Mental health
- Clinical Psychology
- General Neuroscience
Fingerprint
Dive into the research topics of 'Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver